Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Citak, F.
Right arrow Articles by Kurekci, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Citak, F.
Right arrow Articles by Kurekci, A.
Haematologica, Vol 91, Issue 8_Suppl, ECR35-ECR35
Copyright © 2006 by Ferrata Storti Foundation

Journal Article

All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia

FE Citak, U Ezer, E Akkaya, N Ozbulbul, M Bahce, and AE Kurekci

Losev-Losante, Ankara Foundation of Children with Leukemia, Hospital For the Children with Leukemia, Ankara, Turkey.

Anthracyclin-based regimens and all-transretinoic acid (ATRA, tretinoin) as differentiating agent are commonly utilized for the treatment of acute promylelocytic leukemia (APL). There are many adverse effects that may be seen during the use of ATRA in patients with APL. Of these, ATRA-induced myositis is rarely described in adults and rare in the children with APL. Herein, we report an 11-year-old girl with APL who developed ATRA-induced myositis during induction treatment.




HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2006 by the Ferrata Storti Foundation.